|
Personal data - diagnosis
|
Personal data
| Visible name: |
guwipalu |
| Ctry: |
Deutschland |
| State/Province: |
NiedersaCHSEN |
| Year of birth: |
1962 |
| Age: |
62 |
| Occupation: |
Bankkaufmann |
| Hobbies: |
Familie, Moped fahren |
| My Website: |
|
|
Data at initial diagnosis
| Date: |
18.11.2024 |
| Age at diagnosis: |
62 |
| PSA: |
4'492.00 |
| Biopsied? |
Yes |
| TUR-P? |
No |
| Gleason Score: |
3 + 4 = 7a |
| TNM-Stages: |
pT1c pPn1 |
| Remark: |
|
|
|
Maximum measured prostate volume
| Date: |
18.11.2024 |
| PSA: |
4'492.00 |
| Volume in ml or cm³: |
55 ml |
|
Postoperative pathological data
| Date: |
|
| Gleason Score: |
|
| pTNM-classification: |
|
| Margins: |
|
| p-L-V-P-G-Findings: |
|
| See stories of: |
|
|
|
Prostate cancer treatments
** PSA level at the start of the treatment
|
| from |
to |
PSA** |
Type |
Clinic |
City |
|
04.12.24 |
16.12.24 |
4'492.00 |
ADT1 |
MHH |
Hannover |
|
16.12.24 |
|
4'492.00 |
ADT2 |
Urologe |
Hannover |
|
20.12.24 |
|
4'492.00 |
ADT2 |
Urologe |
Hannover |
|
21.01.25 |
28.05.25 |
130.00 |
Chemotherapy |
Vinzenz KKH |
Hannover |
|
11.02.25 |
28.05.25 |
75.00 |
Chemotherapy |
Vinzenz KKH |
Hannover |
|
04.03.25 |
28.05.25 |
34.30 |
Chemotherapy |
Vinzenz KKH |
Hannover |
|
25.03.25 |
28.05.25 |
34.30 |
Chemotherapy |
Vinzenz KKH |
Hannover |
|
15.04.25 |
28.05.25 |
14.90 |
Chemotherapy |
Vinzenz KKH |
Hannover |
|
|
Drugs
NEM = Nutritional supplement
|
| from |
to |
Medication |
Quantity / unit of time |
|
04.12.24 |
16.12.24 |
Bicalutamid |
50mg/T |
|
16.12.24 |
|
Leuprolin 11,25mg |
Dreimonatsspritze |
|
20.12.24 |
|
Darulutamid |
2x 600mg/T |
|
14.01.25 |
|
NEM* Calcium Beta D3 |
1000mg/d |
|
20.01.25 |
08.05.25 |
Dexamethason |
2 x 5mg/d - jeweils drei Tage um den Chemotermin |
|
21.01.25 |
28.05.25 |
Docetaxel |
75mg pro m² KOF - alle drei Wochen 6 Kurse |
|
21.01.25 |
28.05.25 |
MCP |
bei Bedarf max 3 x 10mg /d gegen Übelkeit während der Chemo |
|
23.01.25 |
28.05.25 |
Prednisolon |
jeweils 2 x 8mg an allern anderen Tagen während der Chemo |
Quantity per D / M / Y etc.
|
